TANVEX BIOPHARMA - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 87323886
Serial Number
87323886
Registration Number
6358661
Word Mark
TANVEX BIOPHARMA
Status
700 - Registered
Status Date
2021-05-25
Filing Date
2017-02-03
Registration Number
6358661
Registration Date
2021-05-25
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2021-03-09
Attorney Name
Dyan M. House
Law Office Assigned Location Code
N10
Employee Name
SCHMIDT, JOHN JOSEPH
Statements
Disclaimer with Predetermined Text
"BIOPHARMA"
Goods and Services
Anti-arthritis preparations; anti-inflammatory agent; anticancer drug; antirheumatic preparations; medicines for human purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; western medicines for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; medicinal agent for human use, namely, medicinal herbal preparations; biological preparations for medical purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; haematogen, namely, blood substitutes for human use; chemical preparations for medical purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; pharmaceutical drugs for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; pharmaceutical preparations for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-02-08
Primary Code
005
Current Trademark Owners
Party Name
Tanvex BioPharma, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Tanvex BioPharma, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Tanvex BioPharma, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Tanvex BioPharma, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Dyan M. House
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
CanadaFalse
Trademark Events
Event DateEvent Description
2017-02-07NEW APPLICATION ENTERED IN TRAM
2017-02-08NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-02-23TEAS VOLUNTARY AMENDMENT RECEIVED
2017-03-10ASSIGNED TO LIE
2017-03-30PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
2017-04-29ASSIGNED TO EXAMINER
2017-05-06PRIORITY ACTION WRITTEN
2017-05-06PRIORITY ACTION E-MAILED
2017-05-06NOTIFICATION OF PRIORITY ACTION E-MAILED
2017-09-20TEAS RESPONSE TO OFFICE ACTION RECEIVED
2017-09-23CORRESPONDENCE RECEIVED IN LAW OFFICE
2017-09-23TEAS/EMAIL CORRESPONDENCE ENTERED
2017-10-02APPROVED FOR PUB - PRINCIPAL REGISTER
2017-10-05LAW OFFICE PUBLICATION REVIEW COMPLETED
2017-10-18NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-11-07PUBLISHED FOR OPPOSITION
2017-11-07OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-01-02NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2018-05-02TEAS CHANGE OF CORRESPONDENCE RECEIVED
2018-05-02TEAS EXTENSION RECEIVED
2018-05-02EXTENSION 1 FILED
2018-05-02EXTENSION 1 GRANTED
2018-05-04NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-12-24TEAS EXTENSION RECEIVED
2018-12-24EXTENSION 2 FILED
2018-12-24EXTENSION 2 GRANTED
2018-12-26NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-06-05TEAS EXTENSION RECEIVED
2019-06-05EXTENSION 3 FILED
2019-06-05EXTENSION 3 GRANTED
2019-06-07NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-07-08ASSIGNED TO EXAMINER
2019-12-27TEAS EXTENSION RECEIVED
2019-12-27EXTENSION 4 FILED
2019-12-27EXTENSION 4 GRANTED
2019-12-31NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-07-01TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-07-01TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-07-01ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-07-01TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
2020-07-01TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-07-01APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-07-01TEAS EXTENSION RECEIVED
2020-07-22CASE ASSIGNED TO INTENT TO USE PARALEGAL
2020-07-01EXTENSION 5 FILED
2020-08-11EXTENSION 5 GRANTED
2020-08-12NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-12-18TEAS PETITION TO AMEND BASIS RECEIVED
2021-01-04ASSIGNED TO PETITION STAFF
2021-01-04PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
2021-02-02ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
2021-01-04NOTICE OF ALLOWANCE CANCELLED
2021-02-03CASE RETURNED TO EXAMINATION
2021-02-17NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-03-09PUBLISHED FOR OPPOSITION
2021-03-09OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-05-25REGISTERED-PRINCIPAL REGISTER